Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Vomiting 6Postoperative Nausea and Vomiting 3Neoplasms 3Prostatic Neoplasms 1Pain, Postoperative 1Ovarian Neoplasms 1Nausea 1Myofibroma 1Lung Neoplasms 1Hematologic Neoplasms 1Colonic Neoplasms 1Agnosia 1Adenomyosis 1

Interventions

Misoprostol 5Uterine Myomectomy 3Saline Solution 3relugolix 2dienogest 2carbetocin 2Uterine Artery Embolization 2Tranexamic Acid 2Tourniquets 2Lidocaine 2Leuprolide 2Ascorbic Acid 2ulipristal 1telapristone acetate 1ramosetron 1pirfenidone 1estradiol, norethindrone drug combination 1Vasopressins 1Triptorelin Pamoate 1Tablets 1Sodium Chloride 1Sevoflurane 1Respiration, Artificial 1Remifentanil 1Propofol 1Population Groups 1Oxytocin 1Nuclear Receptor Subfamily 4, Group A, Member 2 1Morcellation 1Methylergonovine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Myofibroma × ramosetron × Clear all
NCT02011659 2013-12-13

PONV

National Health Insurance Service Ilsan Hospital

Phase 3 Unknown
128 enrolled
Gynecologic

Ovarian Neoplasms, Vomiting, Postoperative Nausea and Vomiting, Myofibroma, Adenomyosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡